We are live on
!
Find out more
ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
2L
1
22NW LP
Seattle,
Washington
| $22.8M | +$24.9M | +3,343,565 | New |
|
| 2 |
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.92M | +$3.19M | +428,500 | New |
|
| 3 |
LCM
3
Laurion Capital Management
New York
| $1.55M | +$1.67M | +225,000 | New |
|
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
| $1.2M | +$1.3M | +174,811 | New |
|
| 5 |
BFM
5
Boothbay Fund Management
New York
| $135K | +$148K | +19,835 | New |
|
| 6 |
6
BlackRock
New York
| $53K | +$57.8K | +7,773 | New |
|
| 7 |
7
UBS Group
Zurich,
Switzerland
| $2K | +$1.74K | +234 | New |
|
| 8 |
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | +$1.18K | +158 | New |
|
| 9 |
9
Wells Fargo
San Francisco,
California
| – | +$141 | +19 | New |
|